Regulus Therapeutics Inc. (RGLS) Social Stream
Regulus Therapeutics Inc (RGLS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Regulus Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
RGLS's average price target has moved up $1 over the prior 22 months.
RGLS reports an average of 141.08% for its upside potential over the past 48 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RGLS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 23 months, RGLS's average broker recommendation rating improved by 2.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Regulus Therapeutics Inc's average analyst price target is greater than 0.67% of all US stocks.
- Regulus Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 191.56% of all US stocks.
- RGLS has a higher number of analysts covering the stock than 17.24% of Healthcare stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Regulus Therapeutics Inc's variance in analysts' estimates is lower than 26.36% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Regulus Therapeutics Inc are RDHL, RAPT, and RANI.
Is RGLS a Buy, Hold or Sell? See the POWR Ratings now!